Drugs / cytarbine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00187083 Background | Feb 1997 → Dec 2003 | acute lymphoblastic leukemia | St. Jude Children's Research Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cytarbine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00187083 ↗ |
| Route | Intravenous | “Ara-C: 2 g/m2 IV days 1,2,3,4” NCT00187083 ↗ |